Combination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA.

about

Cephalosporin-Glycopeptide Combinations for Use against Clinical Methicillin-Resistant Staphylococcus aureus Isolates: Enhanced In vitro Antibacterial Activity.

P2860

Q33700986-054E0E0B-B1FD-43E9-8B33-D26739C65969

P2860

Combination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA.

Item

http://www.wikidata.org/entity/Q41869403

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Combination of cephalosporins ...... occus aureus (hVISA) and VISA.

@en

type

Item

label

Combination of cephalosporins ...... occus aureus (hVISA) and VISA.

@en

prefLabel

Combination of cephalosporins ...... occus aureus (hVISA) and VISA.

@en

P1476

Combination of cephalosporins ...... occus aureus (hVISA) and VISA.

@en

P2093

Chi-Chung Chen

http://www.w3.org/2001/XMLSchema#string

Chih-Cheng Lai

http://www.w3.org/2001/XMLSchema#string

Hung-Jen Tang

http://www.w3.org/2001/XMLSchema#string

Yin-Ching Chuang

http://www.w3.org/2001/XMLSchema#string

P2860

Methicillin-resistant Staphylococcus aureus therapy: past, present, and future

Synergy between vancomycin and nafcillin against Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model

Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis.

Efficacy of vancomycin-beta-lactam combinations against heterogeneously vancomycin-resistant Staphylococcus aureus (hetero-VRSA).

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis.

Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains.

Community-associated meticillin-resistant Staphylococcus aureus

P2888

srep41758

P304

41758

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP41758

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28139739

http://www.w3.org/2001/XMLSchema#string

P932

5282487

http://www.w3.org/2001/XMLSchema#string

Combination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA.

about

P2860

P2860

Combination of cephalosporins with vancomycin or teicoplanin enhances antibacterial effect of glycopeptides against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) and VISA.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P577

P698

P932